CYP20A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.473600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.807200E-01
Normal-vs-Stage2
6.334400E-01
Normal-vs-Stage3
1.399770E-01
Normal-vs-Stage4
5.987200E-01
Stage1-vs-Stage2
7.380000E-01
Stage1-vs-Stage3
2.588800E-01
Stage1-vs-Stage4
1.062960E-01
Stage2-vs-Stage3
1.923800E-01
Stage2-vs-Stage4
3.382400E-01
Stage3-vs-Stage4
2.895700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.043000E-01
Normal-vs-AfricanAmerican
8.212000E-01
Normal-vs-Asian
7.533800E-01
Caucasian-vs-AfricanAmerican
2.960000E-01
Caucasian-vs-Asian
9.028000E-01
AfricanAmerican-vs-Asian
5.258400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.362200E-01
Normal-vs-Female
6.781600E-01
Male-vs-Female
7.610600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.712200E-01
Normal-vs-Age(41-60Yrs)
9.178800E-01
Normal-vs-Age(61-80Yrs)
5.825600E-01
Normal-vs-Age(81-100Yrs)
2.157600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.893000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.452800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.972000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.021840E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.281200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.996000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.061000E-01
Normal-vs-Daily Drinker
1.772420E-01
Normal-vs-Weekly Drinker
8.972400E-01
Normal-vs-Occasional Drinker
8.970400E-01
Normal-vs-Social Drinker
8.359200E-01
Non Drinker-vs-Daily Drinker
5.323400E-01
Non Drinker-vs-Weekly Drinker
1.519390E-01
Non Drinker-vs-Occasional Drinker
8.024300E-02
Non Drinker-vs-Social Drinker
2.395200E-01
Daily Drinker-vs-Weekly Drinker
6.955900E-02
Daily Drinker-vs-Occasional Drinker
2.716400E-02
Daily Drinker-vs-Social Drinker
1.237250E-01
Weekly Drinker-vs-Occasional Drinker
9.598200E-01
Weekly Drinker-vs-Social Drinker
8.757000E-01
Occasional Drinker-vs-Social Drinker
8.159000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.739700E-02
Normal-vs-Grade 2
3.166200E-02
Normal-vs-Grade 3
3.079800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.322800E-01
Grade 1-vs-Grade 3
6.521800E-01
Grade 1-vs-Grade 4
6.739700E-02
Grade 2-vs-Grade 3
2.425200E-01
Grade 2-vs-Grade 4
3.166200E-02
Grade 3-vs-Grade 4
3.079800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.295400E-01
Normal-vs-NonDiabetic
5.691200E-01
Diabetic-vs-NonDiabetic
4.100200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.966960E-01
Normal-vs-NoPancreatitis
5.924400E-01
Pancreatitis-vs-NoPancreatitis
3.226600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.553600E-01
Normal-vs-N1
6.530200E-01
N0-vs-N1
9.584600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.616200E-01
Normal-vs-TP53-NonMutant
9.883800E-01
TP53-Mutant-vs-TP53-NonMutant
8.754000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
